177287-18-2

Upstream product

• 177287-28-4 (R)-2-(4-Bromo-benzyloxy)-1-(R)-oxiranyl-ethanol 
• 108267-97-6 (2S,3R)-4-(p-bromobenzyloxy)-2,3-epoxybutan-1-ol 
• 1027046-74-7 Acetic acid (R)-2-(4-bromo-benzyloxy)-1-(R)-oxiranyl-ethyl ester 
• 177287-22-8 Thioacetic acid S-[(2R,3R)-3-(4-bromo-benzyloxymethyl)-oxiranylmethyl] ester 

Downstream Products

• 177584-45-1 Acetic acid (1R,2S)-3-acetoxy-2-acetylsulfanyl-1-(4-bromo-benzyloxymethyl)-propyl ester 

Relevant academic research and scientific papers

Synthesis of [4,5-bis(hydroxymethyl)-1,3-oxathiolan-2-yl]nucleosides as potential inhibitors of HIV via stereospecific base-induced rearrangement of a 2,3-epoxy thioacetate

The synthesis of [4,5-bis(hydroxymethyl)-1,3-oxathiolan-2-yl]nucleosides is described. 2,3-Epoxy alcohol 10 was converted in one pot into thioacetate 11. Treatment of 11 under mild alkaline conditions gave thiirane 12 with inversion of configuration at C-2. We also found that thioacetate 11 rearranges into thiirane 14 under mild acidic conditions. This rearrangement reaction was shown by independent synthesis to proceed with net retention of configuration at C-2. We have proposed a tentative mechanism which may explain the results obtained. Opening of thiiranes 12 and 14 followed by deprotection gave (2R,3R)-2-thiothreitol (23) and (2S,3R)-2-thioerythritol (25), respectively. Regioselective silylation of the primary hydroxyl groups of 23 followed by treatment with trimethyl orthoformate gave 2-methoxy-1,3-oxathiolanes 26 and 27. Condensation with silylated bases followed by deprotection and separation of the anomers gave the oxathiolanyl nucleosides. Compounds 29-31, 34, and 35 were found to be inactive when tested for inhibition of HIV-1 activity in vitro.